UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

Gene therapy, 2000-05, Vol.7 (10), p.867-874

2000

Volltextzugriff (PDF)

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

Neuro-oncology (Charlottesville, Va.), 2012-02, Vol.14 (2), p.132-144

2012

Volltextzugriff (PDF)

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

Human gene therapy, 1999-11, Vol.10 (17), p.2741-2755

1999

Volltextzugriff (PDF)

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice

Gene therapy, 1999-10, Vol.6 (10), p.1751-1758

1999

Volltextzugriff (PDF)

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

Gene therapy, 1999-04, Vol.6 (4), p.564-572

1999

Volltextzugriff (PDF)

Treatment of breast cancer stem cells with oncolytic herpes simplex virus

Cancer gene therapy, 2012-10, Vol.19 (10), p.707-714

2012

Volltextzugriff (PDF)

Preproenkephalin Promoter Yields Region-Specific and Long-Term Expression in Adult Brain after Direct in vivo Gene Transfer via a Defective Herpes Simplex Viral Vector

Proceedings of the National Academy of Sciences - PNAS, 1994-09, Vol.91 (19), p.8979-8983

1994

Volltextzugriff (PDF)

Oncolytic Herpes Simplex Virus Vector with Enhanced MHC Class I Presentation and Tumor Cell Killing

Proceedings of the National Academy of Sciences - PNAS, 2001-05, Vol.98 (11), p.6396-6401

2001

Volltextzugriff (PDF)

Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1

Cancer research (Chicago, Ill.), 1995-11, Vol.55 (21), p.4752-4756

1995

Volltextzugriff (PDF)

Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy

Human gene therapy, 1999-11, Vol.10 (17), p.2869-2878

1999

Volltextzugriff (PDF)

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide

Molecular pharmacology, 1996-08, Vol.50 (2), p.236

1996

Volltextzugriff (PDF)

Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation in Mice

Journal of Virology, 2000-04, Vol.74 (8), p.3832-3841

2000

Volltextzugriff (PDF)

Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates

Journal of Virology, 1999-08, Vol.73 (8), p.6319-6326

1999

Volltextzugriff (PDF)

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1

Human gene therapy, 1998-10, Vol.9 (15), p.2177-2185

1998

Volltextzugriff (PDF)

In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity

Cancer research (Chicago, Ill.), 2001, Vol.61 (1), p.153-161

2001

Volltextzugriff (PDF)

Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant

Cancer research (Chicago, Ill.), 1994-08, Vol.54 (15), p.3963-3966

1994

Volltextzugriff (PDF)

Specific Patterns of Defective HSV-1 Gene Transfer in the Adult Central Nervous System: Implications for Gene Targeting

Experimental neurology, 1994-11, Vol.130 (1), p.127-140

1994

Volltextzugriff (PDF)

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus

Molecular therapy, 2000-12, Vol.2 (6), p.588

2000

Volltextzugriff (PDF)

Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors

Cancer gene therapy, 2000-06, Vol.7 (6), p.939-946

2000

Volltextzugriff (PDF)

Therapeutic Efficacy of G207 in a Novel Peripheral Nerve Sheath Tumor Model

Experimental neurology, 2001-05, Vol.169 (1), p.64-71

2001

Volltextzugriff (PDF)

Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470

Journal of neuro-oncology, 1995, Vol.23 (1), p.23-29

1995

Volltextzugriff (PDF)

Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma

Neoplasia (New York, N.Y.), 1999-06, Vol.1 (2), p.162-169

1999

Volltextzugriff (PDF)

Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (4), p.1532-1540

2005

Volltextzugriff (PDF)

Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain

Gene therapy, 2005-04, Vol.12 (8), p.647-654

2005

Volltextzugriff (PDF)

Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group

Journal of the American Academy of Dermatology, 2016-08, Vol.75 (2), p.356-363

2016

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(140)

Publikationsform

Artikel
(211)

Sprache

Englisch
(198)
Russisch
(13)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

Treatment of breast cancer stem cells with oncolytic herpes simplex virus

Preproenkephalin Promoter Yields Region-Specific and Long-Term Expression in Adult Brain after Direct in vivo Gene Transfer via a Defective Herpes Simplex Viral Vector

Oncolytic Herpes Simplex Virus Vector with Enhanced MHC Class I Presentation and Tumor Cell Killing

Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1

Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide

Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation in Mice

Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1

In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity

Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant

Specific Patterns of Defective HSV-1 Gene Transfer in the Adult Central Nervous System: Implications for Gene Targeting

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus

Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors

Therapeutic Efficacy of G207 in a Novel Peripheral Nerve Sheath Tumor Model

Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470

Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma

Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice

Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain

Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group

Aktive Filter

Suchergebnisse filtern